This abnormality in osteosarcoma generates amplification (CDK4, MDM2, COPS3), gains (RICTOR, TERT) or disruption (TP53, NF1) of driver oncogenes and is localized in chromosomes 5,6,12,13,14,17 [18,86]. This evidence concerns the gene CDK4 and osteosarcoma.